MedPath

et's Sing Out!: The effects of singing on quality of life and lung function of children and adolescents with cystic fibrosis

Completed
Conditions
cystic fibrosis
Human Genetics and Inherited Disorders - Cystic fibrosis
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12609000471280
Lead Sponsor
Jung Yoon Irons
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria

Young people with cystic fibrosis (CF), during exacerbation as inpatients

Exclusion Criteria

lung function measured on spirometry below 20 % of predicted value

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cystic Fibrosis Questionnaire-Revised (CFQ-R), to assess the effects of the singing program on their perceived quality of life (QoL)[pre, post treatment, and at follow-up 4 weeks after completion of singing/control program.];Maximal Inspiratory Pressures using SensorMedics V6200 Autobox (Legacy) total body plethysomograph or P.K. Morgan Pmax pressure manometer (Please note that two Cystic Fibrosis (CF) clinic where the recruitment takes places use different test methods.)[pre, post treatment program, and at follow-up 4 weeks after completion of singing/control program.]
Secondary Outcome Measures
NameTimeMethod
Forced Expiratory Volume in one Second (FEV1) using spirometry[pre, post treatment program, and at follow-up 4 weeks after completion of singing/control program.];Participants' singing is assessed using two simple singing tasks (sing a note for as long as possible, and singing happy birthday song). Participants' singing is recorded using a Zoom Handy Recorder (H4), Sound Pressure Level Meter (Rion NL-06) and a calibrator (B&K 4231).[pre, post treatment program, and at follow-up 4 weeks after completion of singing program.]
© Copyright 2025. All Rights Reserved by MedPath